Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials

Por O'Neil, Patrick M., Aroda, Vanita R., Astrup, Arne, Kushner, Robert, Lau, David C. W., Wadden, Thomas A., Brett, Jason, Cancino, Ana‐Paula, Wilding, John P. H.
Publicado no Diabetes Obes Metab (2017)